Dexmedetomidine Improves Cardiovascular and Ventilatory Outcomes in Critically Ill Patients: Basic and Clinical Approaches

Dexmedetomidine (DEX) is a highly selective α2-adrenergic agonist with sedative and analgesic properties, with minimal respiratory effects. It is used as a sedative in the intensive care unit and the operating room. The opioid-sparing effect and the absence of respiratory effects make dexmedetomidin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Pharmacol
Päätekijät: Castillo, Rodrigo L., Ibacache, Mauricio, Cortínez, Ignacio, Carrasco-Pozo, Catalina, Farías, Jorge G., Carrasco, Rodrigo A., Vargas-Errázuriz, Patricio, Ramos, Daniel, Benavente, Rafael, Torres, Daniela Henríquez, Méndez, Aníbal
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7058802/
https://ncbi.nlm.nih.gov/pubmed/32184718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01641
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia